|Bid||37.17 x 38700|
|Ask||37.19 x 105300|
|Day's range||36.42 - 37.29|
|52-week range||25.95 - 63.60|
|Beta (5Y monthly)||0.90|
|PE ratio (TTM)||9.39|
|Earnings date||09 May 2023|
|Forward dividend & yield||1.35 (3.75%)|
|Ex-dividend date||13 May 2022|
|1y target est||33.60|
Fresenius Medical Care AG & Co. KGaA ( ETR:FME ) came out with its full-year results last week, and we wanted to see...
Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.